BIOHARVEST SCIENCES INC. (CNVCF)
BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET
BioHarvest Sciences to Host a Virtual Investor Webinar on September 10, 2025 at 1:00 PM ET
Precipio Terminates Its ATM
New Form 8-K - CYANOTECH CORP Filed: 2025-09-02 AccNo: 0001437749-25-028099 Size: 171 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
New Form 8-K - TNF Pharmaceuticals, Inc. Filed: 2025-09-02 AccNo: 0001641172-25-026167 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Material Modifications to Rights of Security Holders Item 5.02: Departure of …
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
A New Press Release from Oncolytics Biotech, Inc
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
New Form 8-K - IQVIA HOLDINGS INC. Filed: 2025-09-02 AccNo: 0001193125-25-193510 Size: 175 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications